Conversely, FOXP3 has been reported to be over-expressed in tumor cells in pancreatic adenocarcinoma, melanoma, leukemia, hepatocellular carcinoma, bladder cancer, thyroid carcinoma and cervical cancer [5, 6, 9, 11-13, 28]. Here, FOXP3 is linked to cervical carcinoma.